Estimations des analystes de Wall Street pour Rezolute, Inc. (RZLT): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 12 |
| Conserver | 0 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 12 |
| Note moyenne (1-5) | 1.00 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.14 | ||
| 2026-09-16 | $-0.15 | ||
| 2026-05-12 | $-0.16 | $-0.14 | -12.3% |
| 2026-02-12 | $-0.22 | $-0.16 | -37.5% |
| 2025-11-06 | $-0.18 | $-0.27 | +33.3% |
| 2025-09-17 | $-0.26 | $-0.23 | -13.0% |
| 2025-05-13 | $-0.27 | $-0.22 | -22.7% |
| 2025-02-12 | $-0.22 | $-0.33 | +33.3% |
Ratios de valorisation
| Prix / Valeur comptable | 3.27 |
| EV / EBITDA | -4.86 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coût des Ventes | $8.3M | $12.6M | $1.1M | $48000 | $18000 | $13000 | 0 | 0 | 0 | 0 |
| Marge Brute | -$8.3M | -$12.6M | -$1.1M | -$48000 | -$18000 | -$13000 | 0 | 0 | 0 | 0 |
| R&D | $9.4M | $12.1M | $17.3M | $19.1M | $14.4M | $15.0M | $32.5M | $43.8M | $55.7M | $61.5M |
| Frais Généraux | $5.5M | $8.2M | $9.1M | $6.8M | $6.1M | $7.9M | $9.4M | $12.2M | $14.7M | $18.4M |
| Charges Opérationnelles | $15.0M | $20.3M | $26.4M | $25.9M | $20.5M | $22.9M | $41.8M | $56.0M | $70.4M | $79.9M |
| Résultat Opérationnel | -$15.0M | -$20.3M | -$28.7M | -$25.9M | -$20.5M | -$22.9M | -$41.8M | -$56.0M | -$70.4M | -$79.9M |
| EBITDA | -$14.2M | -$19.2M | -$28.1M | -$25.4M | -$20.3M | -$20.5M | -$39.2M | -$51.8M | -$68.4M | -$74.4M |
| Charges d'Intérêt | $5039 | $1595 | $689188 | $5.0M | 0 | $375000 | $1.8M | 0 | 0 | 0 |
| Résultat Avant Impôts | -$14.9M | -$20.3M | -$29.9M | -$30.4M | -$20.3M | -$20.9M | -$41.1M | -$51.8M | -$68.5M | -$74.4M |
| Impôts | -$19822 | -$11367 | 0 | -$29000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$14.9M | -$20.3M | -$29.9M | -$30.4M | -$20.3M | -$20.9M | -$41.1M | -$51.8M | -$68.5M | -$74.4M |
| BPA | $-30.14 | $-24.55 | $-26.83 | $-17.11 | $-3.54 | $-2.72 | $-2.26 | $-1.01 | $-1.33 | $-0.98 |
| BPA Dilué | $-30.14 | $-24.55 | $-26.83 | $-17.11 | $-3.54 | $-2.72 | $-2.32 | $-1.01 | $-1.33 | $-0.98 |
| Actions en Circulation (Diluées) | $495464 | $825934 | $1.1M | $1.8M | $5.8M | $7.7M | $19.5M | $51.2M | $51.5M | $76.0M |
Prix
| Prix | $3.98 |
| Capitalisation | $383M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: DAWN · EYPT · GERN · KURA · MRVI · NBTX · PRME
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de RZLT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions